Table 1. Baseline characteristics and outcome of 1158 treated patients.
| EVT (n = 712) |
IVT (n = 446) |
|
|---|---|---|
| Age, years (SD) | 71 (13.9) | 72.2 (13.6) |
| Women | 352 (49.4%) | 172 (38.6%) |
| Vascular risk factors | ||
| - Hypertension | 518/710 (73%) | 330/444 (74.3%) |
| - Diabetes mellitus | 132/708 (18.6%) | 82/444 (18.5%) |
| - Atrial fibrillation | 297/610 (48.7%) | 149/394 (37.8%) |
| - Current smoking | 150/578 (26%) | 66/386 (17.1%) |
| - Hypercholesterolemia | 400/697 (57.4%) | 268/443 (60.5%) |
| Baseline NIHSS score, median (range) | 15 (0–36) | 7 (0–36) |
| Vessel occlusion location | ||
| - No occlusion | 0 | 7.6) |
| - Internal carotid artery | 220 (30.9) | 5.8) |
| - Middle cerebral artery | 407 (57.2) | 0.7) |
| - Anterior cerebral artery | 4 (0.6) | 2.7) |
| - Posterior cerebral artery | 14 (2) | 6.3) |
| - Vertebrobasilar system | 67 (9.4) | 31 (7) |
| Treatment | ||
| - EVT without prior IVT | 414/712 (58.1) | - |
| - Bridging therapy (IVT + EVT) | 298/712 (41.9) | - |
| Minutes from symptom onset to treatment, median (range) | 265 (70–1663) | 180 (60–1680) |
| Outcome | ||
| - mRS 0–2 | 253/642 (39.4) | 249/398 (62.6) |
| - Survival | 467/642 (72.7) | 333/398 (83.7) |
| Complications | ||
| - Symptomatic ICH | 32/697 (4.6) | 16/428 (3.7) |
EVT = endovascular treatment, IVT = intravenous thrombolysis